PA
ALSN icon

PharVision Advisers’s Allison Transmission ALSN Stock Holding History

PharVision Advisers’s Portfolio ALSN Stock Details ALSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,615
Closed -$343K – 661
2025
Q2 		$343K Buy
+3,615
New +$349K 0.49% 53

Other funds holding ALSN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's ALSN Position: Q3 2025 in Review

PharVision Advisers sold out of Allison Transmission (ALSN) in Q3 2025, closing a stake of 3,615 shares — an estimated $343K sold.

PharVision Advisers first reported a position in ALSN in Q2 2025 and held it in 1 quarter. The position peaked at $343K in Q2 2025. 512 funds tracked by Wall St. Rank hold ALSN as of Q3 2025.

  • PharVision Advisers reported no remaining Allison Transmission position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,615 Allison Transmission shares in Q3 2025, an estimated $343K.
  • PharVision Advisers first reported a position in Allison Transmission in Q2 2025 and held it in 1 quarter.
  • PharVision Advisers's Allison Transmission position peaked at $343K in Q2 2025.
  • 512 funds tracked by Wall St. Rank held Allison Transmission as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.